Clinical Trials Browser

Phase 3 × osimertinib × CNS × Clear all

NCT02972333 2016-11-23

Open Label, Prospective Study to Investigate Efficacy and Safety of AZD9291 in BM From NSCLC Patients With EGFR T790M

Phase 3 Unknown

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung